Clinical Trials
64 trialsSTARTRK-2
Hoffmann-La Roche
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Pfizer
LEARN
University of Sydney
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Universitaire Ziekenhuizen KU Leuven
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Servier
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Montefiore Medical Center
STARTRK-NG
Hoffmann-La Roche
MOMENTUM
UMC Utrecht
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
CAMPERR
Adela, Inc
AYAConnect
UNC Lineberger Comprehensive Cancer Center
Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors
Thomas Jefferson University
ENGAGE
Maastricht Radiation Oncology
DART
Aalborg University Hospital
EARN
Washington University School of Medicine
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
HadroQoL
CNAO National Center of Oncological Hadrontherapy
CogRT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SPARTA
Apollomics Inc.
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Thomas Jefferson University
MOM
Inova Health Care Services
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Algemeen Ziekenhuis Maria Middelares
Optimization of MRI for Radiation Therapy
University of Michigan Rogel Cancer Center
ROOT
Taproot Health
QUANTUM
VitaMed Research LLC
Dragon
Washington University School of Medicine
Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy
Vanderbilt-Ingram Cancer Center
Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy
Washington University School of Medicine
ALpha-T
Hoffmann-La Roche
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Mayo Clinic
PPTS
P-Cure
Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies
Sunnybrook Health Sciences Centre
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
PIONEER
SpeciCare
In-Room PET in Proton Radiation Therapy
Massachusetts General Hospital
OnkoFit II
University Hospital Tuebingen
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
National Institutes of Health Clinical Center (CC)
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Stanford University
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
IGF Oncology, LLC
N1
CureOne
Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue
University of Michigan
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
AHS Cancer Control Alberta
Assessing the Patient Experience in Cancer Care
Mayo Clinic
Spectroscopy With Surface Coils and Decoupling
Memorial Sloan Kettering Cancer Center